The Lung Cancer Risk Test (LCRT) trial is a prospective cohort study comparing lung cancer incidence among persons with a positive or negative value for the LCRT, a 15 gene test measured in normal bronchial epithelial cells (NBEC). The purpose of this article is to describe the study design, primary endpoint, and safety; baseline characteristics of enrolled individuals; and establishment of a bio-specimen repository.
Douglas A. Arenberg合作论文数6
Peter Mazzone合作论文数Respiratory Institute, Cleveland Clinic6
Pierre Massion合作论文数Vanderbilt University Medical Center5Aaron D Baugh合作论文数4Yeo Jiyoun合作论文数Department of Medicine, University of Toledo Health Sciences Campus4
Sadik A. Khuder (Sadik Khuder)合作论文数Department of Medical, College of Medicine and Life Sciences, University of Toledo4Nana-Sinkam Patrick合作论文数3
James C Willey合作论文数3
Steven D. Nathan合作论文数Lung Transplant Program, Inova Fairfax Hospital3
David E Midthun合作论文数3
Albert M Levin合作论文数Center for Bioinformatics, Henry Ford Health System;Division of Biostatistics, Department of Public Health Sciences, Henry Ford Health System3F. Safi合作论文数2Gerard A Silvestri合作论文数Department of Medicine, Medical University of South Carolina2A. I. Musani合作论文数1Jean Marie Ruddy合作论文数1EL Crawford合作论文数1K. Reno合作论文数1Garber Leonid合作论文数1
Xiaolu Zhang合作论文数1
Julie Ann Pooley合作论文数1David E. Midthun合作论文数1
